Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, Jackson Nyman et al.|Cell Reports|2022Cited by 115
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Rachel Schiff, Chandandeep Nagi et al.|Clinical Cancer Research|2019Cited by 87
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancerRaksha R. Bhat, Meghana V. Trivedi, Puja Yadav et al.|Breast Cancer Research and Treatment|2018Cited by 25
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancerXiaoyong Fu, Rachel Schiff, Resel Pereira et al.|Cell Reports|2023Cited by 20
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft modelsJamunarani Veeraraghavan, Rachel Schiff, Carolina Gutiérrez et al.|npj Breast Cancer|2021Cited by 11